Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose iohexol infusion for measurement of glomerular filtration rate
2010-019933-89Phase 4Terminated
- Sponsor
- St George's, University of London
- Start
- Aug 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of iohexol in chronic kidney disease (CKD) (2 arms), sponsored by St George's, University of London. Primary endpoint: Glomerular Filtration Rate (GFR). Started Aug 2010; status: terminated.
02
Drugs
iohexol
03
Conditions
chronic kidney disease (CKD)
Beyond the preview
Go deeper on 2010-019933-89.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-019933-89.